Millennium Management
LXEO icon

Millennium Management’s Lexeo Therapeutics LXEO Stock Holding History

Millennium Management’s Portfolio LXEO Stock Details LXEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.26M Buy
1,612,780
+704,756
+78% +$4.99M 0.01% 2246
2025
Q4 		$9.02M Sell
908,024
-1,405,618
-61% -$12.8M 0.01% 2374
2025
Q3 		$15.4M Sell
2,313,642
-522,650
-18% -$2.53M 0.01% 1954
2025
Q2 		$11.4M Buy
2,836,292
+1,764,803
+165% +$5.8M 0.01% 2127
2025
Q1 		$3.72M Buy
1,071,489
+929,538
+655% +$4.12M ﹤0.01% 3161
2024
Q4 		$934K Buy
141,951
+104,837
+282% +$826K ﹤0.01% 4258
2024
Q3 		$336K Sell
37,114
-352
-0.9% -$4.2K ﹤0.01% 5124
2024
Q2 		$601K Sell
37,466
-556,256
-94% -$8.08M ﹤0.01% 4474
2024
Q1 		$8.73M Buy
593,722
+549,622
+1,246% +$8.6M 0.01% 2322
2023
Q4 		$592K Buy
+44,100
New +$548K ﹤0.01% 4537

Other funds holding LXEO

PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.71B AUM 374.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return